🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Open label multicentric randomized phase II trial, using high throughput ge...
Status
Completed
Location
Centre Hospitalier Henri Duffau
Start Date
2014-04-23
Trial ID
NCT02117167
To determine the toxicities, maximum tolerated dose (MTD) and recommended p...
Status
Completed
Location
Indiana University Cancer Center
Start Date
2006-10
Trial ID
NCT00408226
Treatments Being Tested
This is an open-label, two-arm, Phase I, dose escalation study to evaluate ...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-11-15
Trial ID
NCT00619424
Treatments Being Tested
This study is for patients with pancreatic cancer that has grown and/or spr...
Status
Terminated
Location
Georgetown University Hospital/Lombardi Cancer Center
Start Date
2007-10
Trial ID
NCT00864513
Treatments Being Tested
This randomized, Phase III, multicenter, open-label study designed to evalu...
Status
Unknown
Location
Samsung Medical Center
Start Date
2019-08-27
Trial ID
NCT03991403
Treatments Being Tested
Immunotherapeutic approaches recently have demonstrated clinical efficacy i...
Status
Recruiting
Location
Aix-en-Provence - CH
Start Date
2022-05-02
Trial ID
NCT05255302
Treatments Being Tested
Patients with malignant pleural mesothelioma stage I-III who have undergone...
Status
Completed
Location
Vivantes Klinikum Neukölln, Klinik für Hämatologie, Onkologie und Palliativmedizin
Start Date
2019-02-04
Trial ID
NCT04177953
Treatments Being Tested
Pemetrexed has demonstrated a favorable response with minimal toxicity when...
Status
Completed
Location
Asan Medical Center
Start Date
2008-07
Trial ID
NCT01490437
Treatments Being Tested
This study will determine the maximum-tolerated dose (MTD) for oral bosutin...
Status
Completed
Location
Augusta University Georgia Cancer Center
Start Date
2019-12-10
Trial ID
NCT03023319
Treatments Being Tested
This is a study to assess the efficacy and safety of pembrolizumab (MK-3475...
Status
Completed
Location
Multiple Locations
Start Date
2014-08-25
Trial ID
NCT02142738
Treatments Being Tested